Lykis Limited Halts Trading for Insiders Ahead of FY26 Results

Lykis Limited has announced a trading window closure for its directors, designated persons, and their immediate relatives, effective April 1, 2026.

This restriction is in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015. The company will keep the window closed until 48 hours after the official announcement of its financial results for the quarter and the full fiscal year ending March 31, 2026.

The purpose of this measure is to prevent potential misuse of unpublished price-sensitive information by insiders. It aims to uphold market integrity and ensure a level playing field for all investors by maintaining transparency during sensitive financial reporting periods.

Lykis Limited operates within India's healthcare and fast-moving consumer goods (FMCG) sectors. Similar trading window closures are a standard practice among listed companies in India, particularly in sectors like pharmaceuticals and healthcare, ahead of earnings announcements to ensure adherence to SEBI's insider trading norms.

Under this closure, directors and specified personnel, along with their immediate families, are prohibited from trading Lykis Limited's shares or other securities. This temporary blackout reinforces the company's commitment to corporate governance and regulatory compliance.

Investors will be looking for the company's official notification regarding the date of the Board Meeting. This meeting is scheduled to consider and approve the financial results for the quarter and year ended March 31, 2026. The reopening date for the trading window will be communicated shortly after the results are made public.